According to The Insight Partners, Cardiac POC Testing Devices Market is expected to register a CAGR of 5.64% from 2026 to 2034, with the market size expanding from US$ 2.79 Billion in 2025 to US$ 4.57 Billion by 2034.
The Cardiac Point-of-Care (POC) Testing Devices Market is expanding rapidly as healthcare providers increasingly prioritize early diagnosis and timely management of cardiovascular diseases (CVDs). Cardiac POC testing devices enable healthcare professionals to rapidly measure critical cardiac biomarkers, including troponin, creatine kinase-MB (CK-MB), and B-type natriuretic peptide (BNP), directly at or near the patient’s location. By delivering diagnostic results faster than conventional laboratory-based testing, these devices support prompt clinical decision-making and facilitate the early initiation of appropriate treatment.
Get a Sample PDF – https://www.theinsightpartners.com/sample/TIPRE00040780
This rapid diagnostic capability is critical in emergency departments, ambulatory care centers, and remote healthcare settings, where immediate clinical decisions can directly impact patient survival outcomes.
According to the referenced market study by The Insight Partners, the Cardiac POC Testing Devices Market is expected to grow steadily through 2034, driven by rising cardiovascular disease prevalence, expanding healthcare infrastructure, and continuous technological advancements in diagnostic platforms. Increasing adoption of portable and user-friendly devices is further transforming cardiac care delivery by enabling faster triage and improving clinical workflow efficiency.
Market Drivers Fueling Growth in Cardiac POC Testing Devices Market
One of the primary growth drivers of the Cardiac POC Testing Devices Market is the alarming global rise in cardiovascular diseases. CVDs remain the leading cause of mortality worldwide, with increasing incidence driven by aging populations, sedentary lifestyles, obesity, diabetes, and hypertension. This growing disease burden has intensified the need for rapid diagnostic solutions that can support early detection and immediate treatment decisions, particularly in emergency and critical care settings.
Another major driver is the growing preference for decentralized healthcare and near-patient testing. Hospitals and clinics are increasingly adopting POC diagnostics to reduce laboratory dependency and improve patient throughput. Cardiac POC testing devices help eliminate delays associated with central laboratory processing, enabling faster rule-in and rule-out of acute myocardial infarction (AMI) cases, which is crucial in emergency medicine.
Cardiac POC Testing Devices Market: Size, Share, Trends, Analysis, and Forecast to 2034
- Market Size: The Cardiac POC Testing Devices Market is expected to expand significantly through 2034, driven by increasing demand for rapid cardiovascular diagnostics and near-patient testing.
- Market Share: North America is anticipated to account for a substantial market share owing to advanced healthcare infrastructure, high adoption of point-of-care technologies, and the presence of leading diagnostic companies.
- Market Trends: Growing adoption of portable and automated cardiac testing devices, increasing use of digital diagnostics, and integration of connectivity features are key trends shaping the market.
- Growth Drivers: The rising prevalence of cardiovascular diseases, growing geriatric population, increasing emphasis on early diagnosis, and demand for faster clinical decision-making are supporting market growth.
- Technology Trends: Advances in cardiac biomarker detection, including troponin, CK-MB, and BNP testing, are improving the speed and efficiency of point-of-care cardiac diagnostics.
- Market Analysis: Healthcare providers are increasingly adopting POC testing devices to reduce diagnostic turnaround times, support emergency care, and facilitate timely treatment decisions.
- Application Outlook: Cardiac POC testing devices are gaining importance across emergency departments, hospitals, clinics, ambulatory care centers, and other decentralized healthcare settings.
- Regional Outlook: North America and Europe are expected to remain important markets, while Asia Pacific is projected to offer significant growth opportunities due to expanding healthcare infrastructure and increasing healthcare expenditure.
- Forecast to 2034: Continued technological innovation, rising cardiovascular disease burden, and increasing preference for rapid and decentralized diagnostic solutions are expected to create favorable growth opportunities through 2034.
Market Segmentation and Regional Insights
The market is segmented based on product type, biomarker type, end user, and geography. Hospitals and emergency care centers dominate end-user adoption due to high patient inflow and critical care requirements. However, ambulatory care centers and home healthcare segments are expected to witness faster growth due to increasing decentralization of healthcare services.
Regionally, North America holds a significant share of the Cardiac POC Testing Devices Market due to advanced healthcare infrastructure, high awareness levels, and strong adoption of innovative diagnostic technologies. Europe follows closely, supported by robust healthcare systems and increasing focus on early disease detection. Meanwhile, Asia-Pacific is projected to witness the fastest growth due to rising healthcare investments, growing population base, and increasing burden of cardiovascular diseases.
Competitive Landscape and Key Players
The Cardiac POC Testing Devices Market is highly competitive, with several global and regional players focusing on product innovation, strategic partnerships, and geographic expansion. Key companies operating in the market include:
- Abbott Laboratories
- Roche Diagnostics
- Siemens Healthineers
- Danaher Corporation (Beckman Coulter)
- QuidelOrtho Corporation
- Becton, Dickinson and Company (BD)
- bioMérieux SA
- Trinity Biotech plc
- Nova Biomedical Corporation
- Radiometer Medical (a Danaher company)
These companies are investing heavily in R&D to develop next-generation cardiac diagnostic solutions with improved sensitivity, faster turnaround time, and enhanced connectivity features.
Get Premium Market Research Report Here:
https://www.theinsightpartners.com/buy/TIPRE00040780
Future Outlook (By 2034)
By 2034, the Cardiac POC Testing Devices Market is expected to evolve into a highly digitized and integrated ecosystem. Increasing adoption of AI-powered diagnostic tools, expansion of home-based cardiac care, and continued innovation in biomarker detection will redefine the market landscape. The growing emphasis on preventive healthcare and early disease detection will further strengthen the demand for rapid cardiac diagnostic solutions globally.
About Us
The Insight Partners is a one-stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.
Contact Us
Ankit Mathur | The Insight Partners
E-mail: ankit.mathur@theinsightpartners.com
Phone: +1-646-491-9876
